Histiocytic Sarcoma Risk Test Clinic

Offered for purebred BMDs in conjunction with the health clinics at the 2022 National Specialty

Mercury Ballroom, Embassy Suites Hotel, Spa & Conference Center 

*Significantly subsidized by BMDCA; the normal fee per dog is 115 Euros = ~$130 USD + shipping to France**

**Samples from this clinic will be shipped to Antagene at BMDCA expense provided sample(s) are received during clinic hours

Blood samples will be drawn at the clinic. You can also hand deliver blood samples directly to the clinic from dogs at home; mailed samples will not be accepted. 

Samples delivered to the clinic should be kept cool (not frozen) in transit to the Specialty. (Please refer to the Home Instructions below.)

If you are not attending the National Specialty, find a friend to deliver your sample(s) for you. 

The Antagene test for Histiocytic Sarcoma gives results expressed as a genetic index, which is based on the statistical analysis of nine genetic markers identified from the scientific research on the Bernese Mountain Dog. It is a selection tool and does not constitute a predictive test for the development of this cancer. It is a genetic tool to assist breeders in the management of their kennels and decisions on matings, using the Histiocytic Sarcoma Index Mate Selection tool (HSIMS), to enable them to reduce the incidence of Histiocytic Sarcoma in the population of Bernese Mountain Dogs. The test is not an endpoint but a continuation of the research on Histiocytic Sarcoma. The test will be optimized and refined with advanced research. For this, your participation is essential. Dogs participating in this clinic will be marked as "tested" in the Berner-Garde database, but the index score will not be included. NOTE: By participating in this clinic, you acknowledge that DNA extracted from your dog's sample may be used for genetic research. Contact Julie Jackson at [email protected] if you have questions about the HS Risk Test clinic, cell (206) 930-3290